Virtu Financial’s Atrium Therapeutics RNA Stock Holding History
Bought
Maintained
Sold
Other funds holding RNA
Virtu Financial's RNA Position: Q3 2026 in Review
Virtu Financial opened a new position in Atrium Therapeutics (RNA) in Q3 2026: 11,280 shares worth $93K. The stake represents ﹤0.01% of the portfolio and ranks #1186 among its holdings.
148 funds tracked by Wall St. Rank hold RNA as of Q3 2026.
- Virtu Financial held 11,280 shares of Atrium Therapeutics worth $93K as of Q3 2026.
- Atrium Therapeutics was a new Virtu Financial position in Q3 2026.
- Atrium Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q3 2026, its #1186 holding.
- 148 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.